Gaush

Gaush Meditech Ltd, listed on the Hong Kong Stock Exchange in December 2022, has over 20 years of experience advancing eye health. The company provides integrated ophthalmic solutions covering R&D, manufacturing, sales, training, and technical services. GLOBAL VISION HK LTD. serves as its Hong Kong branch.

Product & Reach
Gaush offers 120+ products across diagnosis, treatment, instruments, and consumables, serving seven sub-specialties. Its network reaches over 4,000 Chinese customers, including 1,000+ Class III hospitals.

Partnerships & Services
Built on professionalism and integrity, Gaush holds exclusive China partnerships with 16 global ophthalmic leaders. Value-added services include Gaush Service (120+ engineers across 30+ provinces, 12,000+ annual technical services) and Gaush Online—China’s first professional ophthalmology e-learning platform with 50,000+ WeChat followers.

R&D & Vision
With two overseas R&D centers (Netherlands, Germany) and five domestic centers, Gaush develops premium IOLs, electrophysiological systems, diagnostic equipment, surgical instruments, and consumables. Through continuous innovation, Gaush aims to become a leading global ophthalmic total solution provider.